ライフサイエンスコーパス: New York

1 EA) performed by very low-volume surgeons in New York.

2 ary intervention or in-hospital mortality in New York.

3 o CLS epidemics in the monoculture fields in New York.

4 d Trends (CASTNET) sites in Pennsylvania and New York.

5 at 3 pediatric long-term care facilities in New York.

6 an environments of Los Angeles, Chicago, and New York.

7 h; San Francisco, California; and the Bronx, New York.

8 f cardiogenic shock from public reporting in New York.

9 hcare facilities in California, Florida, and New York.

10 s of 24 participating oncologists in western New York.

11 , Florida (1.5%; 95% range, -7.4 to 14), and New York (1.9%; 95% range, -6.4 to 9.8).

12 3(H7N9), A/Netherlands/219/2003(H7N7), and A/New York/107/2003(H7N2)] or with human A(H1N1)pdm09 (A/C

13 The virus isolated from the human case, A/New York/108/2016 (NY/108), caused mild and transient il

14 awaii (2006-2010), Nebraska (2003-2011), and New York (2005-2012).

15 nrolled mothers who delivered live births in New York (2008-2010).

16 h hospital discharge claims from Florida and New York (2008-2011), patients who underwent 1 of 32 gen

17 tient Databases from Florida (2009 to 2013), New York (2010 to 2013), and California (2009 to 2011).

18 the states of California (years 2009-2011), New York (2011-2013), and Florida (2012-2014).

19 nts with AMI and cardiogenic shock (11298 in New York), 21 974 (47.8%) underwent PCI.

20 7-1.02; P=0.152 for post- versus pre-2010 in New York; adjusted relative risk, 0.88; 95% confidence i

21 In 2013, 1416 women in New York aged 20 to 49 years underwent BCS compared with

22 nuary 1, 2002, through December 31, 2012, in New York and a series of comparator states (Massachusett

23 Discharge data on 268518 patients from New York and California (derivation cohort) and 153560 p

24 Of the 268 518 patients from New York and California (derivation cohort), 151 009 (56

25 Data derived from patients in the New York and California State Inpatient Database were re

26 nuary 1, 2008, through December 31, 2011, in New York and California to evaluate a final sample of 42

27 usted risks of in-hospital mortality between New York and comparator states after 2010 were also simi

28 : cardiogenic shock excluded permanently) in New York and compared with Michigan.

29 was conducted of discharge records from 349 New York and Florida hospitals between January 1, 2008,

30 xed-cropping farms and monoculture fields in New York and Hawaii, USA, were genotyped (n = 600) using

31 farction complicated by cardiogenic shock in New York and Michigan, 905 (42.6%) were women and mean (

32 ock with similar baseline characteristics in New York and Michigan.

33 ncomp coverage shifted to Medicaid, while in New York and nonexpansion state sites, reliance on RWHAP

34 and hospital-based cancer clinics in Western New York and Northern California.

35 and hospital-based cancer clinics in Western New York and Northern California; 38 medical oncologists

36 spread to multiple shelters in the states of New York and Pennsylvania.

37 diac arrest January 2003 to December 2013 in New York and several comparator states.

38 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan.

39 ospital and community practices in New York, New York, and Chicago, Illinois.

40 y clams in Connecticut, oysters and clams in New York, and denitrification are not included.

41 d community oncology practices in Rochester, New York, and Sacramento, California.

42 he country's TB burden: California, Florida, New York, and Texas.

43 He grew up in Brooklyn, New York, and took his undergraduate degree at Johns Hop

44 olumbia University Medical Center, New York, New York, and Tulane University Medical Center, New Orle

45 In 2006, New York began excluding patients with cardiogenic shock

46 In 2013, New York began requiring hospitals to follow protocols f

47 as Ashkenazi Jewish and participated in the New York Breast Cancer Study (NYBCS) from 1996 to 2000 w

48 on clinics and 5 community-based programs in New York, California, and North Carolina.

49 ce the 1990s, tuberculosis (TB) incidence in New York City (NYC) and the United States (US) has flatt

50 pollution and preterm birth using 2008-2010 New York City (NYC) birth certificates linked to hospita

51 (9H) has historically been low (<50%) among New York City (NYC) Health Department tuberculosis clini

52 Beginning in 2002, New York City (NYC) implemented numerous policies and pr

53 ren exposed to measles during an outbreak in New York City (NYC) in 2013.

54 diagnosis and the start of an outbreak at a New York City (NYC) university.

55 Two New York City academic medical centers.

56 le with population estimates in the areas of New York City affected by Hurricane Sandy.

57 2713 simulated agents living in the areas of New York City affected by Hurricane Sandy.

58 the highest areas of poverty and assault in New York City and has adequate data to analyze these pat

59 the highest areas of poverty and assault in New York City and has adequate data to analyze these pat

60 at occurred during an outbreak among cats in New York City animal shelters.

61 ernal urine in a cohort of women enrolled in New York City between 1998 and 2002 (n = 404).

62 then estimated future heat-related deaths in New York City by combining the changing temperature-mort

63 jections of temperature-related mortality in New York City by taking into account future patterns of

64 The flood hazard in New York City depends on both storm surges and rising se

65 s collected at 150 street-level locations in New York City during December 2008-November 2009: alumin

66 ed CD4(+) T-cell counts and viral loads from New York City for persons who received a diagnosis of HI

67 tions to assess future coastal inundation in New York City from the preindustrial era through 2300 CE

68 a deterministic match between people in the New York City HIV surveillance registry alive as of 1 Ja

69 t public health threat since the outbreak in New York City in 1999.

70 heights associated with tropical cyclones in New York City in coming centuries to increase greatly co

71 ockefeller Institute for Medical Research in New York City in July 1965.

72 a community sample of employed adults in the New York City metropolitan area (2005-2012), and the Nat

73 aused mass intoxication of 33 persons in one New York City neighborhood, in an event described in the

74 the observed population response to heat in New York City over the course of eight decades.

75 es amplified directly from DNA isolated from New York City park soils.

76 A comparison of sequences derived from New York City parks to genes involved in the biosynthesi

77 and forecast at sub-municipal scales within New York City provides richer, more discriminant informa

78 his study included 1 065 562 students within New York City public elementary schools and middle schoo

79 ards." We obtained 3,592,026 BMI reports for New York City public school students for 2007-2012.

80 oximately 3 million rides extracted from the New York City taxicab public dataset.

81 sets - including items lost and found on the New York City transit system, library books, and a bacte

82 urban heat-related mortality: estimates for New York City under multiple population, adaptation, and

83 People with HIV in New York City were frequently hospitalized.

84 und 1970 and place the ancestral US virus in New York City with 0.99 posterior probability support, s

85 ons (SSTIs) associated with handling fish in New York City's Chinatown.

86 We find that New York City's flood hazard has increased significantly

87 intake with the use of the standards of the New York City's National Salt Reduction Initiative (NSRI

88 n 2008 and 2010 in New York state (excluding New York City) whose parents completed developmental scr

89 high-latitude cities; in the other, Queens (New York City), most taxa declined with warming, perhaps

90 slands, measurements made in Central Park in New York City, and the standard agreed upon by the Unite

91 d mortality risks across the 21st century in New York City, and they highlight the importance of both

92 15 Hispanics/Latinos, 18-74 years of age, in New York City, Chicago, Miami, and San Diego.

93 the ongoing leakage of refrigerant gases in New York City, compounds that either deplete the stratos

94 years of age at enrollment (2004-2007) from New York City, greater Cincinnati, Ohio, and the Bay Are

95 s), medium (Seattle, Washington), and large (New York City, New York) metropolitan markets.

96 He attended Stuyvesant High School in New York City, Philadelphia College of Pharmacy and Scie

97 Using data on millions of taxi trips in New York City, San Francisco, Singapore, and Vienna, we

98 ve source of an outbreak in a cat shelter in New York City, which subsequently spread to multiple she

99 phagous fly species in the Manhattan area of New York City.

100 mation, in the multi-ethnic BioMe biobank in New York City.

101 re affect influenza forecast accuracy within New York City.

102 agents are actually present in the soils of New York City.

103 initiation has been reduced substantially in New York City.

104 targeting persons originating from Africa in New York City.

105 ot to the overall effect of BMI reporting in New York City.

106 tter, nitrogen dioxide, and preterm birth in New York City.

107 lic schools with prekindergarten programs in New York City.

108 rm tracks moving offshore at the latitude of New York City.

109 lization rates among people with HIV/AIDS in New York City.

110 rs in 3 safety-net primary care practices in New York City.

111 anges in the SIJs were assessed based on the New York criteria of 1966.

112 ity: 90% vs. 94% on radiographs according to New York criteria.

113 eons performed OAR and 1071 performed CEA in New York during the study period.

114 tient Databases in the states of Florida and New York during the years 2009 to 2013 for patients over

115 ents discharged from California, Florida and New York emergency departments (EDs) and acute care hosp

116 Recognizing this, the State of New York enacted Public Health Law (NY PBH Law) 2803-o i

117 with high demand charges like California and New York, even without subsidies.

118 of historical WNV outbreaks in Long Island, New York for 2001-2014.

119 Rates of revascularization in New York for cardiac arrest patients were lower througho

120 PCI outliers in 2 states (Massachusetts and New York) from 2002 to 2012.

121 >/=40 years in northern Manhattan (New York, New York) had annual assessments with the Barthel index

122 nd the use of PCI for elective procedures in New York has decreased substantially between 2010 and 20

123 n, functional outcome, defined as changes in New York Heart Assocation class and 6-minute walking dis

124 ion: Patients at an average age of 64 years, New York Heart Association (NYHA) class II to IV heart f

125 Patients (aged >/=18 years) with New York Heart Association (NYHA) class III chronic hear

126 centre study that enrolled participants with New York Heart Association (NYHA) Class III heart failur

127 22 (96%) of 23 patients were New York Heart Association (NYHA) class III or IV at bas

128 Patients newly diagnosed with symptomatic New York Heart Association (NYHA) functional class >/=II

129 ovember 2015 and June 2016, 15 patients with New York Heart Association (NYHA) functional class >/=II

130 t-related variables that are associated with New York Heart Association (NYHA) functional class and t

131 ariables, ranking biomarkers associated with New York Heart Association (NYHA) Functional class and t

132 ore was 3.98 +/- 1%; 54% of patients were in New York Heart Association (NYHA) functional class I and

133 L amyloidosis included sex, Karnofsky index, New York Heart Association (NYHA) functional class, dias

134 as defined as an improvement by at least one New York Heart Association (NYHA) functional class.

135 score, quality of life (QOL), and change in New York Heart Association (NYHA) functional classificat

136 2, patients in group 3 had a higher-rate of New York Heart Association 3 to 4 (26% versus 12% and 10

137 tomatic at the time of index echocardiogram (New York Heart Association [NYHA] functional class II: 4

138 onitoring of Pressure to Improve Outcomes in New York Heart Association [NYHA] Functional Class III H

139 onitoring of Pressure to Improve Outcomes in New York Heart Association [NYHA] Functional Class III H

140 % had connective tissue disease, 52% were in New York Heart Association class >/=III, and mean pulmon

141 F were older (67 versus 62 years), had worse New York Heart Association class (III/IV; 36% versus 24%

142 re no correlations between baseline IVSd and New York Heart Association class (P=0.067), Canadian Car

143 The proportion of patients in New York Heart Association class 3 to 4 was reduced from

144 At follow-up, 77% of patients were in New York Heart Association class I or II (P<0.001 versus

145 1).m(-2), 6-minute walk distance >440 m, and New York Heart Association class I or II functional clas

146 ve at 62+/-13 years of age, including 89% in New York Heart Association class I or II.

147 eft ventricular function, and all but 1 have New York Heart Association class I symptoms.

148 an did HFrEF patients with low fatigability (New York Heart Association class I), despite similar lef

149 erquartile range, 25-41 years; 58% male; 90% New York Heart Association class I).

150 eft ventricular ejection fraction </=35% and New York Heart Association class II to III were randomly

151 sand three hundred ninety-nine patients with New York Heart Association class II to IV HF with reduce

152 omly assigned 8399 patients with chronic HF, New York Heart Association class II to IV symptoms, and

153 on fraction </=35%, QRS width >/=130 ms, and New York Heart Association class II, III, or ambulatory

154 Importantly, HFrEF New York Heart Association class II-III patients with EI

155 ry 2014, patients at outpatient clinics with New York Heart Association class II-IV heart failure and

156 High-risk ambulatory patients with New York Heart Association class II-IV symptoms of heart

157 h left ventricular ejection fraction >/=40%, New York Heart Association class II-IV, elevated pulmona

158 pe (left ventricular ejection fraction <40%, New York Heart Association class II-IV, sinus rhythm, an

159 nitoring of Pressures to Improve Outcomes in New York Heart Association Class III Heart Failure Patie

160 , blinded multicenter trial in patients with New York Heart Association class III or ambulatory class

161 as associated with outcome, many patients in New York Heart Association class III or IV at baseline i

162 patients from 31 sites in North America with New York Heart Association class III or IV symptomatic h

163 d, 5 within 30 days; all 22 patients were in New York Heart Association class III or IV, and 9 were h

164 d as symptomatic congestive heart failure of New York Heart Association class III or IV, confirmed by

165 ge was 40 years, and 71% of patients were in New York Heart Association class III or IV.

166 nal study enrolled 166 patients with chronic New York Heart Association class III-IV HF, ejection fra

167 9+/-11 years old, and 49% men, predominately New York Heart Association class III/IV status.

168 Using multivariable analysis, New York Heart Association class III/IV, RVESRI, and log

169 Mean New York Heart Association class improved from 2.7+/-0.8

170 lthough it is typically not considered among New York Heart Association class IV (NYHA IV) heart fail

171 Frailty was associated with New York Heart Association class IV heart failure, lower

172 r CRT whereas 19 (28.8%) showed no change in New York Heart Association class or worsened (nonrespond

173 New York Heart Association class was significantly impro

174 ctors of perforation were history of stroke, New York Heart Association class, and number of stents u

175 Baseline IVSd was not correlated with New York Heart Association class, Canadian Cardiology So

176 ences identified in terms of study duration, New York Heart Association class, ejection fraction, and

177 thickness and left atrial volume, and worse New York Heart Association class, HF-specific quality of

178 For 22 of the 40 patients (55%), the New York Heart Association classification was class II a

179 +/- 14.3 years; 469 men [65.5%]; 577 [80.6%] New York Heart Association function class I/II), 83 (11.

180 dian; HR, 1.99; 95% CI, 1.32-3.04; P<0.001), New York Heart Association functional class >/=3 (HR, 1.

181 C-treated patients displayed improvements of New York Heart Association functional class (P=0.0167 ve

182 Questionnaire score, 6-minute walk time, and New York Heart Association functional class at 6 months.

183 Improvements in symptom class (79% in New York Heart Association functional class I or II at f

184 p of 15 +/- 4 months, symptom improvement to New York Heart Association functional class I or II occu

185 s reported mild or no symptoms at follow-up (New York Heart Association functional class I or II).

186 n 3 centers (44 +/- 17 years; 66% male) with New York Heart Association functional class I/II symptom

187 ing stroke occurred in 2.5% of patients, and New York Heart Association functional class I/II was obs

188 age 67 +/- 9 years) with exertional dyspnea (New York Heart Association functional class II to III, l

189 On multivariable analysis, pre-procedure New York Heart Association functional class III and IV h

190 rillation (p < 0.001), dialysis (p < 0.001), New York Heart Association functional class III or IV (p

191 score was 6.4 +/- 5.5%; 86% of patients were New York Heart Association functional class III or IV, a

192 ors of mortality included cardiac variables (New York Heart Association Functional Class III or IV, p

193 centers including patients with chronic HF, New York Heart Association functional class III symptoms

194 art failure symptoms due to obstructive HCM (New York Heart Association functional class III).

195 ccurrence (the primary endpoint), defined as New York Heart Association functional class III/IV sympt

196 (age 82.7 +/- 5.5 years, 67.5% female, 68.0% New York Heart Association functional class III/IV).

197 0.91-0.95), hemodialysis (3.25; 2.42-4.37), New York Heart Association functional class IV (1.25; 1.

198 Mortality was associated with New York Heart Association functional class IV (hazard r

199 New York Heart Association functional class or Ross clas

200 unction (echocardiography), clinical status (New York Heart Association functional class or Ross clas

201 At first follow-up RHC (n=763), New York Heart Association functional class, 6-minute wa

202 Quality of life, New York Heart Association functional class, and 6-min w

203 ignificantly lower exercise tolerance, worse New York Heart Association functional class, and higher

204 with recurrent ICD shocks, whereas advanced New York Heart Association functional class, longer VT c

205 (10%) developed progressive heart failure to New York Heart Association functional classes III/IV.

206 azone is contraindicated in patients with HF>New York Heart Association I, despite some benefits sugg

207 monary hypertension, renal or liver disease, New York Heart Association III/IV symptoms, transaortic

208 ment and functional class as assessed by the New York Heart Association improved on FCM versus standa

209 ent status (6% versus 4%, P=0.01), and worse New York Heart Association status (P<0.001).

210 changes in standard functional assessments (New York Heart Association, quality of life, 6-minute wa

211 ective OAR or CEA from 2000 to 2014 from all New York hospitals.

212 isits to acute care hospitals in Florida and New York in 2013 using data from the Healthcare Cost and

213 e criteria were applied to PCIs performed in New York in patients without acute coronary syndromes or

214 ected on a salt marsh island in Jamaica Bay, New York, in April 2015 and the root was cross-sectioned

215 hort of 11,481 World Trade Center workers in New York, including 6,133 never smokers without a previo

216 motor milestones in a US cohort.The Upstate New York Infant Development Screening Program (Upstate K

217 primary hypothesis tested the effect of the New York law on racial/ethnic disparities, using Califor

218 healthy ethnically diverse residents of the New York metropolitan area using Positron Emission Tomog

219 cities (Berlin, Delhi NCT, Mexico City, and New York metropolitan area) applying a consistent method

220 ttle, Washington), and large (New York City, New York) metropolitan markets.

221 Madrid, Spain; Stockholm, Sweden; New York, New York; Miami, Florida; and Houston, Texas (date range

222 rospective study of children in Long Island, New York (n = 260).

223 sons aged >/=40 years in northern Manhattan (New York, New York) had annual assessments with the Bart

224 d December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan.

225 hma from hospital and community practices in New York, New York, and Chicago, Illinois.

226 centers (Columbia University Medical Center, New York, New York, and Tulane University Medical Center

227 and 2012-2013 and included a sample of 1227 New York, New York, public elementary schools and middle

228 ssed whether a supportive housing program in New York, New York, was effective in improving housing s

229 d Kingdom; Madrid, Spain; Stockholm, Sweden; New York, New York; Miami, Florida; and Houston, Texas (

230 ic medical centers in Boston, Massachusetts; New York, New York; Pittsburgh, Pennsylvania; and San Di

231 using the Web of Science (Thompson-Reuters, New York, NY) to identify any associated first-in-human

232 and efficacy of E10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) a

233 New York PBH Law 2803-o was implemented on January 1, 20

234 patients with ongoing cardiogenic shock from New York PCI public reports in 2006 was associated with

235 centers in Boston, Massachusetts; New York, New York; Pittsburgh, Pennsylvania; and San Diego, Calif

236 2013 and included a sample of 1227 New York, New York, public elementary schools and middle schools a

237 ut, Georgia, Maryland, Michigan, New Jersey, New York, Puerto Rico, and Texas from 1996 to 2012.

238 11 Memorial & Museum's "Tribute in Light" in New York, quantifying behavioral responses with radar an

239 nd State Inpatient Database from Florida and New York ranging from 2009 to 2013.

240 from all inpatient units of Suffolk County, New York (response rate, 72%).

241 and weight measurements collected as part of New York's FITNESSGRAM initiative.

242 In New York sites, both RWHAP/Uncomp (20% and 19%) and Medi

243 y were infants born between 2008 and 2010 in New York state (excluding New York City) whose parents c

244 strictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011.

245 sician attitudes toward public scorecards in New York State (NYS) have been studied, but the exclusio

246 her risk of mortality compared with those in New York State (odds ratio 2.35, confidence interval 2.2

247 ficantly higher in the England compared with New York State [11,604 (13.6%) vs 3633 (6.9%) patients,

248 act procedures from California, Florida, and New York state ambulatory surgery settings were identifi

249 mergency laparotomy between populations from New York State and England might identify factors that c

250 mergency laparotomy between populations from New York State and England.

251 In 2010, New York State began excluding selected patients with ca

252 mandatory state databases in California and New York State between January 1, 1998, and December 31,

253 The New York State Cancer Registry and Statewide Planning an

254 gnosed from 2001 to 2012 and reported to the New York State Cancer Registry.

255 A mandatory New York State database was queried and 5,475 patients w

256 s and septic shock that were reported to the New York State Department of Health from April 1, 2014,

257 ns (PCIs) classified as "inappropriate." The New York State Department of Health shared rates with ho

258 The Commonwealth Fund and the New York State Department of Health.

259 gency laparotomy in England as compared with New York State despite similar patient groups.

260 ZKV testing was initiated in January 2016 in New York State for symptomatic patients, pregnant women,

261 ed to capture patients undergoing surgery in New York State from 2000 to 2013.

262 ed to capture patients undergoing surgery in New York State from 2000 to 2013.

263 t a reoperation within 90 days of BCS across New York State from 2011 to 2013, compared with 2 in 5 f

264 CU patients rehospitalized within 30 days in New York State hospitals between 2008 and 2013.

265 om January 1, 2003, to December 31, 2013, in New York State mandatory reporting databases.

266 eluting stent or CABG were selected from the New York State registries.

267 hospitals and ambulatory surgery centers in New York State were included.

268 onal cohort study assessed 345 patients from New York State with an urgent or emergency admission to

269 mented to test all clinical cases of MTBC in New York State, including isolates and early positive Ba

270 In California and New York State, the overall standardized incidence of in

271 (61.9%) from England and 52,583 (38.1%) from New York State, were extracted.

272 inpatient and ambulatory surgery settings in New York State.

273 treatment plant (WWTP) in the Albany area of New York State.

274 break in cats in multiple animal shelters in New York State.

275 Using New York statewide longitudinal administrative data, 38,

276 Episode Statistics (HES) in England and the New York Statewide Planning and Research Cooperative Sys

277 The New York Statewide Planning and Research Cooperative Sys

278 Trends were confirmed using the New York Statewide Planning and Research Cooperative Sys

279 fornia, Oregon, and Maryland), 4 in a state (New York) that expanded Medicaid in 2001, and 2 in nonex

280 , Illinois, Massachusetts, Pennsylvania, and New York) that made up the intervention group with chang

281 trial conducted at 2 urban EDs in the Bronx, New York, that included 416 patients aged 21 to 64 years

282 ocation and ownership perspective, though in New York, these emissions can be reduced with careful ta

283 rates of PCI for AMI and shock were lower in New York throughout the study.

284 Neural activity in response to 80 New York Times articles was observed in theory-driven re

285 ing death: California, Illinois, New Jersey, New York) to those from non-accommodation states.

286 aucoma testing ranged from 0% in Binghamton, New York, to as high as 35% in 2 other communities.

287 en aged 20 to 70 years, including 19364 from New York (treatment group) and 22982 from California (co

288 sample of patients seeking evaluation at the New York University Langone Medical Center Adult ADHD Pr

289 rtment of Child and Adolescent Psychiatry at New York University Langone Medical Center.

290 ponse Analyzer (Reichert Instruments, Depew, New York, USA) and RNFL measurements were obtained at ea

291 eener (Spot; Welch Allyn, Skaneateles Falls, New York, USA) for detection of amblyopia risk factors i

292 16 from patients in the Lower Hudson Valley, New York using a previously validated EV-D68-specific rR

293 er a supportive housing program in New York, New York, was effective in improving housing stability a

294 yland, North Carolina, Nebraska, New Jersey, New York, Washington, and Wisconsin), allowing compariso

295 Before 2010, patients with cardiac arrest in New York were less likely to undergo percutaneous corona

296 rdial infarction and cardiac arrest (5619 in New York) were included.

297 ption being urban and rural populations from New York which were nearly identical.

298 mple of 1348 participants from Bronx County, New York, who were 70 years or older without dementia at

299 used an outbreak in the Lower Hudson Valley, New York with 160 laboratory-confirmed cases.

300 risk of in-hospital death among patients in New York with AMI and shock decreased significantly fast

301 Hospital admissions data from the state of New York with information on primary payer as well as pa